It might be faster towards the end because they can say to people that this data has been reviewed 2-3 times and continuation of trial after each stage means its chances of being futile are less likely.
Ann: Phase 3 Trial in COVID-19 ARDS Surpasses 50% Enrollment, page-21
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.40 |
Change
0.020(1.45%) |
Mkt cap ! $1.569B | |||
| Open | High | Low | Value | Volume |
| $1.40 | $1.41 | $1.39 | $414.1K | 296.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 25100 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 1745 | 4 |
View Market Depth
| Last trade - 10.10am 17/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |